Delivery Order SPE2DR25D6028-SPE2DR26FAQXE
Award Date 10/24/25
Potential Completion Date 11/21/25
Potential Value $4.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,111.77 for MULTIHANCE 529MG/ML 5S, a contrast agent pharmaceutical product, by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. This firm fixed price, non-competitive set-aside delivery order is due for completion by October 3, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Multihance 529 mg/ml vials (10 ml) valued at $2,203.22 under a firm fixed price contract type. The award was made on October 23, 2025, with an ultimate completion date of October 24, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office...
- The Defense Logistics Agency awarded a $4,057.92 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Omnipaque 350 mg/ml Pluspak 500ml, a diagnostic contrast agent used in medical imaging procedures. This firm fixed-price contract, with completion targeted for September 10, 2025, represents a competitively awarded, non-set-aside delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The pharmaceutical distributor, headquartered in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,989.50 firm fixed-price Delivery Order, awarded on November 8, 2022, is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a medical product. The contract has an ultimate completion date of November 9, 2022 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MULTIHANCE 529 MG/ML VIAL 10ML. The $2,609.26 firm fixed-price contract has a completion date of June 28, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML medical products. The contract, valued at $6,100.40, is a firm fixed-price delivery order with a completion date of September 6, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $2,503.35 delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Visipaque 320 mg/ml in 100ml bottles, a contrast medium used in medical imaging procedures. This firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX valued at $999,999,999.00 through December 2026), carries no set-aside designation and is scheduled...
- The Defense Logistics Agency awarded a delivery order under an indefinite-delivery/indefinite-quantity contract vehicle to Amerisourcebergen Drug Corporation for the supply of 20 vials of MultiHANCE 529 MG/ML contrast agent at a value of $5,631.23. Performance will take place in Conshohocken, Pennsylvania from June 30 through July 3, 2023. The firm-fixed-price order was awarded without any socioeconomic set-asides and will support the medical imaging needs of the Department of Defense through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,175.30 to AmerisourceBergen Drug Corp for the supply of Gadavist 1 mmol/ml bulk vials (30ml). This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a small-value...
- This federal contract award is for the delivery of MULTIHANCE 529 MG/ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $14,541.00 and an ultimate completion date of July 27, 2023. This delivery order contract is a firm fixed-price arrangement. The contract was awarded on July 26,...